Fundraising FoxBiostax
Winter Park, US · Founded 2023 · Florida corporation · 1 known investors
Find your way into Biostax
Each arrow is one introduction. Sign up to fill in the first one.
1 person can intro you to Noreen
Ask Michael Handley to introduce you to Noreen Griffin
You →Michael · together at Biostax →Noreen
Sign up to find every way you can get introduced to Biostax
- Your email: who you already know at Biostax, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Biostax team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
NG
Noreen GriffinExecutiveNoreen Griffin is CEO of Biostax Corp, a company developing immunology-focused therapeutics, and brings 30 years of experience in biotech and energy sectors, including prior roles as EVP at clinical-stage Cytocom Inc. and CFO at ERHC Energy Inc. She holds patents related to low-dose naltrexone and has overseen regulatory approvals for Lodonal in multiple countries.
AD
Angus DalgleishExecutive
SE
Seth ElliottPresident and Chief Operating Officer
PA
Peter AronstamChief Financial Officer
FS
Fengping ShanChief Science Officer
JF
Joseph FortunakExecutive
Board
CP
Christopher PearceBoard director
ET
Edward TeraskiewiczBoard director
VB
Vincent ButtaBoard director
EY
Eugene YoukilisBoard director
NP
Nicholas PlotnikoffNon-Executive Chairman of the Board (non-voting director)
Investors · 1
Deal Boxreported
How we know: prnewswire.com · Not right? Tell us
Funding
SEC filings, press & company announcements$600K disclosed across 2 of 5 rounds · 2015–2025
▶$7.5MofferedJun 2026 · 20 investors · BiotechnologyRule 506(b)
▶$7.5MofferedJun 2026 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Noreen GriffinExecutive Officer
- Offering amount
- $7.5M
- Minimum investment
- $10K
- First sale
- Dec 2025
- Incorporated
- Corporation, Florida, 2023
- Federal exemptions
- 06b
▶$5MofferedAug 2022 · BiotechnologyRule 506(b)
▶$5MofferedAug 2022 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Roscoe MooreDirector
- Robert WilsonDirector
- Glen FarmerExecutive Officer
- Clifford SelskyDirector
- Cynthia DouglasExecutive Officer
- Noreen GriffinExecutive Officer
- Kevin PhelpsDirector
- Stephen WilsonExecutive Officer, Director
- Kelly WilsonExecutive Officer
- Offering amount
- $5M
- Minimum investment
- $25K
- Sales commissions
- $500K
- Proceeds to insiders
- $120K
- Placement agents
- JBCG Enterprises, Dealbox
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
▶$400KraisedAug 2022 · 1 investors · BiotechnologyRule 506(b)
▶$400KraisedAug 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Cynthia DouglasExecutive Officer
- Stephen WilsonExecutive Officer, Director
- Clifford SelskyDirector
- Roscoe MooreDirector
- Kevin PhelpsDirector
- Robert WilsonDirector
- Offering amount
- $400K
- Amount sold
- $400K
- First sale
- Jul 2022
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
▶$200KraisedApr 2015 · 1 investors · BiotechnologyRule 506(b)
▶$200KraisedApr 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Christopher PearceDirector
- Edward TeraskiewiczDirector
- Noreen GriffinExecutive Officer, Director
- Angus DalgleishExecutive Officer
- Vincent ButtaDirector
- Seth ElliottExecutive Officer
- Eugene YoukilisDirector
- Nicholas PlotnikoffDirector
- Peter AronstamExecutive Officer
- Fengping ShanExecutive Officer
- Joseph FortunakExecutive Officer
- Amount sold
- $200K
- First sale
- Mar 2015
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Biostax's investors?
- Biostax's investors include Deal Box.
- How much funding has Biostax raised?
- Biostax has disclosed $600K raised across 2 of its 5 known rounds.
- Where is Biostax headquartered?
- Biostax is headquartered in Winter Park, US.